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Corticosteroid sparing agents are used to control the underlying 
disease, reduce the side effects of corticosteroid therapy, and facilitate tapering 
off. The frequently used corticosteroid sparing agents are azathioprine, 
mycophenolate mofetil, hydroxychloroquine, and cyclophosphamide. Lupus 
nephritis occurs mostly in children and the main therapy used is long-term 
corticosteroids that can lead to organ damage, which should be treated by 
providing corticosteroid sparing agent. 
This study was done to analyze the drug utilization profile as well as 
the tapering off pattern of corticosteroid and corticosteroid sparing agents and 
furthermore to identify potential adverse effects of corticosteroid sparing agent 
in pediatric patients with LN. The study used observational method that was 
analyzed descriptively on 37 patients with hospitalization period of January 
2016 until December 2017. 
The profile of corticosteroid sparing agent in patients with LN were 
combination of oral MMF and oral chloroquine, in which oral cyclosporine A 
was added in certain conditions, and combination of IV CPA pulse and oral 
chloroquine. The tapering off pattern of oral prednisone in the presence of 
corticosteroid sparing agent was in accordance with the Clinical Practice 
Guide, which was decrease of 5 mg / day every month. Actual adverse effects 
included leucopenia (34%), hepatotoxicity (13%), and GIT disorders (45%). 
The corticosteroid sparing agent profile in pediatric patients with LN 
in Dr. Soetomo Hospital was in accordance with the Clinical Practice Guide 
(PPK) issued by Dr. Soetomo General Hospital. Both regular monitoring of 
patients as well as enhanced interprofessional collaboration are required to 
monitor adverse effects of corticosteroid sparing agents. 
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